- Home
- CTNM vs CRNT Comparison
CTNM vs CRNT Comparison
Compare CTNM & CRNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTNM
- CRNT
- Stock Information
- Founded
- CTNM 2009
- CRNT 1996
- Country
- CTNM United States
- CRNT Israel
- Employees
- CTNM N/A
- CRNT N/A
- Industry
- CTNM
- CRNT Radio And Television Broadcasting And Communications Equipment
- Sector
- CTNM
- CRNT Technology
- Exchange
- CTNM Nasdaq
- CRNT Nasdaq
- Market Cap
- CTNM 248.7M
- CRNT 218.8M
- IPO Year
- CTNM 2024
- CRNT 2000
- Fundamental
- Price
- CTNM $12.36
- CRNT $1.99
- Analyst Decision
- CTNM Strong Buy
- CRNT Strong Buy
- Analyst Count
- CTNM 4
- CRNT 4
- Target Price
- CTNM $22.75
- CRNT $5.50
- AVG Volume (30 Days)
- CTNM 278.0K
- CRNT 548.4K
- Earning Date
- CTNM 11-05-2025
- CRNT 11-12-2025
- Dividend Yield
- CTNM N/A
- CRNT N/A
- EPS Growth
- CTNM N/A
- CRNT 34.68
- EPS
- CTNM N/A
- CRNT 0.15
- Revenue
- CTNM N/A
- CRNT $380,518,000.00
- Revenue This Year
- CTNM N/A
- CRNT N/A
- Revenue Next Year
- CTNM N/A
- CRNT $7.19
- P/E Ratio
- CTNM N/A
- CRNT $13.39
- Revenue Growth
- CTNM N/A
- CRNT 5.06
- 52 Week Low
- CTNM $3.35
- CRNT $1.82
- 52 Week High
- CTNM $20.30
- CRNT $5.73
- Technical
- Relative Strength Index (RSI)
- CTNM 73.06
- CRNT 45.17
- Support Level
- CTNM $10.30
- CRNT $1.97
- Resistance Level
- CTNM $13.26
- CRNT $2.07
- Average True Range (ATR)
- CTNM 1.04
- CRNT 0.06
- MACD
- CTNM 0.03
- CRNT 0.01
- Stochastic Oscillator
- CTNM 77.13
- CRNT 42.86
About CTNM Contineum Therapeutics Inc. Class A Common Stock
Contineum Therapeutics Inc is a clinical stage biopharmaceutical company focused on discovering and developing novel, oral small molecule therapies for NI&I indications with high unmet need. Its internally-discovered drug candidates, PIPE-791 and PIPE-307, PIPE-791, is a novel, brain penetrant, small molecule inhibitor of the LPA1R in development for IPF and PIPE-307, is a novel, small molecule selective inhibitor of the muscarinic type 1 M1R, in development for depression and RRMS.
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and wide distribution of its business, providing high-capacity wireless connectivity solutions to markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the key revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.